#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chorioretinitis Castleman's disease Neuroblastoma recurrent Primary hyperoxaluria Infantile apnoea Lymphangiosarcoma Hepato-lenticular degeneration Acquired C1 inhibitor deficiency Conjunctivitis allergic Chronic lymphocytic leukaemia recurrent Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Primary adrenal insufficiency Oesophageal adenocarcinoma Colitis ulcerative Leukocyte adhesion deficiency type I More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome – Treatment KBG syndrome – Trials in Disease Crigler-Najjar syndrome – Basic Information Methylmalonic acidaemia Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Burkitt’s lymphoma – Basic Information SAPHO syndrome – Treatment Focal segmental glomerulosclerosis – Diagnostics Combined immunodeficiency – Diagnostics Mitochondrial myopathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    11902A Panobinostat Pasireotide Diaspartate Elacestrant Gns561 Phleum Pratense Pollen Extract TRIACYLGLYCEROL LIPASE M1P Dipotassium Salt Polydextrose Fosaprepitant Meldonium Daunorubicin Hydrochloride Casimersen Nacystelyn Cortisone Nazartinib Amlodipine Besilate Selpercatinib Vanglusagene Ensiparvovec Davutamig More therapies…

    Learn about Your Condition

    Meningococcal infection Osteosarcoma recurrent Peripheral artery stenosis Obsessive-compulsive disorder Hepatic adenoma Pseudomyxoma peritonei Lumbosacral radiculopathy Acute myeloid leukaemia Acute kidney injury Vaginal haemorrhage Intestinal obstruction Giant cell arteritis Thromboangiitis obliterans Pelvic venous thrombosis Vascular dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Safety, tolerability and efficacy of topical human fibroblasts in patients with chronic refractory wounds (two-part study)

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • HUMAN FIBROBLASTS
    Italy

  • Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Phleum Pratense
    • Sodium Chloride
    Spain

  • Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis

    Not yet recruiting

    2 1
    Bulgaria Czechia France Germany Poland

  • Evaluating measles, mumps, rubella vaccine (live) in lactating women to enhance infant mucosal immunity

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Rubella Virus Wistar Ra 27/3 Strain (Live, Attenuated) Produced In Wi-38 Human Diploid Lung Fibroblasts
    Belgium

  • Study of teclistamab plus autologous lymphocyte infusion in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Teclistamab
    Italy

  • Safety and Preliminary Efficacy of Oral GSK5460025A Alone or with Drug Combination in Adult Patients with dMMR/MSI‑H Colorectal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • GSK5460025A
    Denmark France Italy The Netherlands Spain Sweden
Previous Page
1 … 722 723 724 725 726 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!